PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1913443
PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1913443
U.S. Ophthalmic Sutures Market was valued at USD 399.9 million in 2025 and is estimated to grow at a CAGR of 3% to reach USD 560.1 million by 2035.

The growth is fueled by rising demand for advanced ophthalmic surgeries, an increase in the prevalence of eye disorders, and the expanding adoption of minimally invasive procedures. Ophthalmic sutures are vital for hospitals, specialized eye-care centers, and ambulatory surgical facilities, ensuring precise wound closure, improved surgical outcomes, and greater efficiency in procedures involving cataract, corneal, retinal, and glaucoma interventions. The market is further supported by a growing volume of surgeries, technological advancements in absorbable and non-absorbable sutures, and a focus on materials designed for optimal handling, reduced tissue reactivity, and predictable postoperative healing. Increasing surgeon awareness and the shift toward higher-quality surgical solutions are also driving market expansion across the U.S. as the population ages and chronic ocular conditions rise.
| Market Scope | |
|---|---|
| Start Year | 2025 |
| Forecast Year | 2026-2035 |
| Start Value | $399.9 Million |
| Forecast Value | $560.1 Million |
| CAGR | 3% |
The synthetic sutures segment held 69.2% share in 2025, due to high demand for durable, biocompatible, and minimally reactive materials. Surgeons favor synthetic sutures for their predictable absorption rates and reduced risk of postoperative complications, especially in delicate procedures such as cataract surgeries, corneal transplants, and vitreoretinal interventions.
The coated sutures segment generated USD 157.5 million in 2025 and is expected to grow at a CAGR of 2.8% through 2035. Coated sutures, enhanced with protective layers such as silicone or polyglactin, facilitate smoother passage through ocular tissues, minimize trauma, and accelerate wound healing, supporting high-precision surgeries.
South Atlantic Ophthalmic Sutures Market held a 19.4% share in 2025. States like Florida, Georgia, North Carolina, and South Carolina have a large aging population, driving higher ophthalmic surgery volumes. Well-established hospitals and specialty clinics with advanced surgical infrastructure further support the adoption of premium sutures.
Key players in the U.S. Ophthalmic Sutures Market include Accutome, Alcon, Assut Medical, Aurolab, B. Braun, Corza Medical, DemeTECH, Ethicon, FCI Ophthalmics, Geuder AG, Mani, Medtronic, Peters Surgical, Rumex International, Surgical Specialties Corporation, and Teleflex Incorporated. Companies in the U.S. Ophthalmic Sutures Market are strengthening their position through strategic collaborations with hospitals and surgeons, expanding product portfolios to include advanced synthetic and coated sutures, and investing in R&D to improve handling, absorption, and biocompatibility. Many are focusing on minimally invasive procedure compatibility and enhanced postoperative outcomes to differentiate their offerings. Marketing initiatives, surgeon training programs, and global regulatory compliance further enhance brand credibility.